VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,572,000 | +51.4% | 508,900 | +1.5% | 0.13% | +38.5% |
| Q1 2018 | $10,284,000 | +1179.1% | 501,400 | +1533.2% | 0.10% | +1271.4% |
| Q4 2017 | $804,000 | +101.0% | 30,700 | +12.9% | 0.01% | +133.3% |
| Q1 2017 | $400,000 | -26.9% | 27,200 | -3.2% | 0.00% | -40.0% |
| Q4 2016 | $547,000 | -78.2% | 28,100 | -64.0% | 0.01% | -80.0% |
| Q3 2016 | $2,511,000 | -40.6% | 78,016 | -51.9% | 0.02% | -47.9% |
| Q2 2016 | $4,226,000 | -85.6% | 162,216 | -81.2% | 0.05% | -87.6% |
| Q1 2016 | $29,395,000 | -75.8% | 863,300 | 0.0% | 0.39% | -72.7% |
| Q4 2015 | $121,345,000 | -47.9% | 863,300 | -13.0% | 1.41% | -47.6% |
| Q3 2015 | $232,748,000 | -12.8% | 992,678 | +1.2% | 2.70% | -5.7% |
| Q2 2015 | $266,797,000 | +26.4% | 980,878 | +13.6% | 2.86% | +29.7% |
| Q1 2015 | $211,130,000 | +79.1% | 863,478 | +18.6% | 2.21% | +76.6% |
| Q4 2014 | $117,888,000 | +25.4% | 728,178 | +10.8% | 1.25% | +26.9% |
| Q3 2014 | $93,992,000 | -14.6% | 657,178 | -20.3% | 0.98% | -17.7% |
| Q2 2014 | $110,042,000 | +29.5% | 824,678 | +38.3% | 1.20% | +17.6% |
| Q1 2014 | $85,002,000 | -1.8% | 596,378 | -15.3% | 1.02% | -7.5% |
| Q4 2013 | $86,534,000 | +37.7% | 704,278 | +20.1% | 1.10% | +33.8% |
| Q3 2013 | $62,831,000 | +77.6% | 586,378 | +50.2% | 0.82% | -4.8% |
| Q2 2013 | $35,381,000 | – | 390,278 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |